BCL2L1 anticorps
Aperçu rapide pour BCL2L1 anticorps (ABIN135021)
Antigène
Voir toutes BCL2L1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Specificité
- Human/Mouse/Rat/Rhesus Bcl-xL
-
Attributs du produit
- Mouse Anti-Bcl-xL-UNLB
-
Purification
- Purified
-
Immunogène
- Recombinant human Bcl-xS
-
Isotype
- IgG3
-
-
-
-
Indications d'application
-
- Applications: FC - Quality tested , IHC-PS - Reported in literature , ICC - Reported in literature , WB - Reported in literature , IP - Reported in literature , ELISA - Reported in literature
- Working Dilutions: Flow Cytometry FITC and BIOT conjugates 3 g/106 cells PE conjugate 0.3 g/106 cells For flow cytometry, the suggested use of these reagents is in a final volume of 100 L Immunoblotting Purified (UNLB) antibody 1 g/mL
-
Volume d'échantillon
- 1 mL
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 0.1 mg/mL
-
Buffer
- 0.1 mg of purified immunoglobulin in 1.0 mL of borate buffered saline, pH 8.2. No preservatives or amine-containing buffer salts added
-
Agent conservateur
- Without preservative
-
Conseil sur la manipulation
- Each reagent is stable for the period shown on the bottle label if stored as directed.
-
Stock
- 4 °C
-
Stockage commentaire
- Store at 2-8°C
-
-
-
: "The ability of Bcl-x(L) and Bcl-2 to prevent apoptosis can be differentially regulated." dans: Cell death and differentiation, Vol. 3, Issue 1, pp. 113-8, (2006) (PubMed).
-
: "The ability of Bcl-x(L) and Bcl-2 to prevent apoptosis can be differentially regulated." dans: Cell death and differentiation, Vol. 3, Issue 1, pp. 113-8, (2006) (PubMed).
-
- BCL2L1 (BCL2-Like 1 (BCL2L1))
-
Autre désignation
- Bcl-xL
-
Sujet
- Apoptosis, or programmed cell death, is a well-documented phenomenon in many cellular systems. It plays a key role in tissue and organ development as well as in adult tissues during cell turnover. Apoptosis can be induced by a variety of internal and external stimuli including growth factor deprivation, cytokine treatment, antigen-receptor engagement, cell-cell interactions, irradiation and glucocorticoid treatment. Bcl-2 and one of its homologues, Bcl-xL, protect cells from apoptosis, while other homologues of Bcl-2 such as Bax, Bad and Bak have been shown to enhance apoptosis. Bcl-xL has been shown to block apoptosis which is induced by a variety of stimuli and, under certain conditions, offers greater protection against apoptosis than Bcl-2. In contrast, Bad and Bax inhibit the protective functions of Bcl-xL and Bcl-2, respectively. Although heterodimerization between Bcl-xL/Bad and Bcl-2/Bax was originally thought to be essential for the differential anti-apoptotic activity of Bcl-xL and Bcl-2, other results suggest that the formation of heterodimers may not be necessary for this death-repressing activity.
-
Pathways
- Apoptose, Negative Regulation of intrinsic apoptotic Signaling
Antigène
-